These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 47211)
1. Clinical tolerance and catabolism of plasmin-treated gamma-globulin for intravenous application. Barandun S; Castel V; Makula MF; Morell A; Plan R; Skvaril F Vox Sang; 1975; 28(3):157-75. PubMed ID: 47211 [TBL] [Abstract][Full Text] [Related]
2. Anticomplementary properties of plasmin-treated human G immunoglobulin and its components. Skvaril F; Gozze I Int Arch Allergy Appl Immunol; 1978; 57(4):315-8. PubMed ID: 149091 [TBL] [Abstract][Full Text] [Related]
3. [Prophylaxis and therapy with gamma globulin. General characterization and clinical use of gamma globulin preparations]. Barandun S; Skvaril F; Morell A Schweiz Med Wochenschr; 1976 Apr; 106(16):533-42. PubMed ID: 62393 [TBL] [Abstract][Full Text] [Related]
4. Antibody spectrum and anticomplementary activity of a plasmin-treated human immunoglobulin preparation. Masuda K; Makula MF; Okuyama K; Ishiyama H; Yasuda J Vox Sang; 1982 Jan; 42(1):8-15. PubMed ID: 6460384 [TBL] [Abstract][Full Text] [Related]
5. [Intravenous administration of immunoglobulin preparations in clinical practice ( review of foreign literature)]. Sharygin SL; Sapozhnikova VS Klin Med (Mosk); 1991 Jul; 69(7):20-3. PubMed ID: 1719271 [No Abstract] [Full Text] [Related]
6. The preparation of plasmin treated immune serum globulin for intravenous use. Sgouris JT Vox Sang; 1967 Jul; 13(1):71-84. PubMed ID: 4166592 [No Abstract] [Full Text] [Related]
7. Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease. Cunningham-Rundles C; Smithwick EM; Siegal FP; Day NK; Lion A; O'Malley J; Barandun S; Good RA Birth Defects Orig Artic Ser; 1983; 19(3):201-3. PubMed ID: 6197105 [No Abstract] [Full Text] [Related]
8. Isolation of Fab and Fc fragments from a plasmin-treated human immunoglobulin by high-speed gel filtration on TSK G3000SW and G3000SWG. Watabe S; Takada K; Shitori Y; Hashimoto K Vox Sang; 1985; 48(1):1-7. PubMed ID: 3155887 [TBL] [Abstract][Full Text] [Related]
9. Intravenous gamma globulin. Metabolism of gamma globulin fragments in normal and agammaglobulinemic persons. Janeway CA; Merler E; Rosen FS; Salmon S; Crain JD N Engl J Med; 1968 Apr; 278(17):919-23. PubMed ID: 4171301 [No Abstract] [Full Text] [Related]
10. Clinical use of intravenous gamma-globulin. Barandun S; Morell A; Skvaril F Bibl Haematol; 1980; (46):170-4. PubMed ID: 6155121 [No Abstract] [Full Text] [Related]
11. [Studies on the properties of the component of plasmin-treated IgG and the relation between IgG aggregates and complement-fixing ability (author's transl)]. Funakoshi S Hokkaido Igaku Zasshi; 1974 Nov; 49(6):522-35. PubMed ID: 4283370 [TBL] [Abstract][Full Text] [Related]
12. [Behavior of serum immunoglobulins during and after intravenous administration of gamma globulin in subjects with antibody deficiency syndromes]. Gravina E; Gravina-Sanvitale G Minerva Pediatr; 1975 Jun; 27(20):1166-70. PubMed ID: 49009 [No Abstract] [Full Text] [Related]
13. [Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections]. Duswald KH; Ring J Klin Anasthesiol Intensivther; 1980; 21():207-23. PubMed ID: 6161270 [No Abstract] [Full Text] [Related]
14. [FAB immunoglobulin fragments. I. The comparative characteristics of the serological and virus-neutralizing properties of a gamma globulin against tick-borne encephalitis and of the FAB fragments isolated from it]. Barban PS; Minaeva VM; Pantiukhina AN; Startseva MG Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):51-7. PubMed ID: 60019 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of primary immunodeficiencies with intravenous gamma globulin]. García Rodríguez C; López Trascasa M; Ferreira Cerdán A; Fontán Casariego G An Esp Pediatr; 1987 Dec; 27(6):411-5. PubMed ID: 2451892 [TBL] [Abstract][Full Text] [Related]